FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034403791> ?p ?o ?g. }

• W3034403791 endingPage "1570" @default.
• W3034403791 startingPage "1570" @default.
• W3034403791 abstract "Background: As with other connective tissue diseases, fibromyalgia (FMS) syndrome is not uncommon in scleroderma. However, there is no clear information about it in the literature. According to 1990 ACR criteria, sensitive point evaluation was made in scleroderma and FMS frequency was reported as 18.6% in scleroderma patients. However, it is known that fibrosis creates difficulties in sensitive point determination. moreover, ACR 1990 criteria cannot be met in approximately 25% of fibromyalgia patients. Therefore, the frequency of fibromyalgia in scleroderma patients is unclear. In 1990, ACR announced new criteria in 2010 due to the low sensitivity of ACR criteria to FMS detection and not being used in the follow-up of the disease. In the new set of criteria, not the 18 sensitive point evaluations, but the Widespread Pain Index and Symptom Severity Scale are evaluated. Objectives: In this study, we planned to investigate the frequency of fibromyalgia in systemic sclerosis patients according to the new ACR criteria defined in 2010. Methods: 43 patients with diffuse systemic sclerosis with no known additional diseases were included in the study. Patients were evaluated with the new fibromyalgia diagnostic criteria set. Patients were evaluated with Fibromyalgia Impact Questionnaire (FIQ), Pain Location Score (PLS), Symptom Impact Questionnaire (SEA), Widespread Pain Index (WPI) and Symptom Severity Scale (SSS). Results: The mean age of the patients was 53.45 ± 12.87 years (39 women, 4 men). Mean values were FIQ: 46.05 ± 17.44, PLS:18.32 ± 9.87, SEA: 20.76 ± 11.31, WPI: 7.93 ± 5.87, SSS: 6.51 ± 3.41 respectively. According to these results, 62.8% (n: 27) FMS presence of SS patients was detected. Conclusion: In the literature, there are only a few studies evaluating the frequency of FMS in scleroderma patients. Malcarne et al. reported that 18.6% of 102 SSc patients met the 1990 classification criteria for FMS. However, there are predominantly early-stage systemic sclerosis patients in this study and the patient group is heterogeneous. We included patients with diffuse systemic sclerosis and widespread skin involvement in this study. we found a much higher frequency of fibromyalgia syndrome than indicated in the literature. Considering that systemic sclerosis is a serious disease that significantly impairs quality of life, this finding is very important. In order to relieve the symptoms associated with FMS, it is important to provide them with additional medical support, to provide as much exercise as possible, and to provide group therapies to improve patients’ quality of life. References: [1]Management of Musculoskeletal Involvement in Systemic Sclerosis. Philip Clements. Curr Treatm Opt Rheumatol. 2016 Mar; 2(1): 61–68. [2]Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH, Furst DE, Clements PJ, Weisman MH. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol. 2007;34:359–367. Disclosure of Interests: None declared" @default.
• W3034403791 created "2020-06-19" @default.
• W3034403791 creator A5005181524 @default.
• W3034403791 creator A5031026205 @default.
• W3034403791 creator A5066086202 @default.
• W3034403791 date "2020-06-01" @default.
• W3034403791 modified "2023-09-27" @default.
• W3034403791 title "AB0547 INVESTIGATION OF THE PRESENCE OF FIBROMYALGIA SYNDROME IN PATIENTS WITH SCLERODERMA" @default.
• W3034403791 doi "https://doi.org/10.1136/annrheumdis-2020-eular.5411" @default.
• W3034403791 hasPublicationYear "2020" @default.
• W3034403791 type Work @default.
• W3034403791 sameAs 3034403791 @default.
• W3034403791 citedByCount "0" @default.
• W3034403791 crossrefType "journal-article" @default.
• W3034403791 hasAuthorship W3034403791A5005181524 @default.
• W3034403791 hasAuthorship W3034403791A5031026205 @default.
• W3034403791 hasAuthorship W3034403791A5066086202 @default.
• W3034403791 hasConcept C126322002 @default.
• W3034403791 hasConcept C142724271 @default.
• W3034403791 hasConcept C180032290 @default.
• W3034403791 hasConcept C1862650 @default.
• W3034403791 hasConcept C198451711 @default.
• W3034403791 hasConcept C2777831278 @default.
• W3034403791 hasConcept C2779967694 @default.
• W3034403791 hasConcept C71924100 @default.
• W3034403791 hasConceptScore W3034403791C126322002 @default.
• W3034403791 hasConceptScore W3034403791C142724271 @default.
• W3034403791 hasConceptScore W3034403791C180032290 @default.
• W3034403791 hasConceptScore W3034403791C1862650 @default.
• W3034403791 hasConceptScore W3034403791C198451711 @default.
• W3034403791 hasConceptScore W3034403791C2777831278 @default.
• W3034403791 hasConceptScore W3034403791C2779967694 @default.
• W3034403791 hasConceptScore W3034403791C71924100 @default.
• W3034403791 hasIssue "Suppl 1" @default.
• W3034403791 hasLocation W30344037911 @default.
• W3034403791 hasOpenAccess W3034403791 @default.
• W3034403791 hasPrimaryLocation W30344037911 @default.
• W3034403791 hasRelatedWork W1117630921 @default.
• W3034403791 hasRelatedWork W173975581 @default.
• W3034403791 hasRelatedWork W1972052278 @default.
• W3034403791 hasRelatedWork W2022749089 @default.
• W3034403791 hasRelatedWork W2059767201 @default.
• W3034403791 hasRelatedWork W2130326520 @default.
• W3034403791 hasRelatedWork W2319205027 @default.
• W3034403791 hasRelatedWork W2971140590 @default.
• W3034403791 hasRelatedWork W2973166306 @default.
• W3034403791 hasRelatedWork W3215015290 @default.
• W3034403791 hasVolume "79" @default.
• W3034403791 isParatext "false" @default.
• W3034403791 isRetracted "false" @default.
• W3034403791 magId "3034403791" @default.
• W3034403791 workType "article" @default.